{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiblkgiz2ut5phuzw3mxx2s2fojtirgbwtzmmijglxq2cseouocski",
    "uri": "at://did:plc:6pwit4ctv4egvys3qyqmgbi6/app.bsky.feed.post/3mm4r5ehio6z2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreie7xwehdm4nbkt2sr3rquvwalbon7iin2ep3n3cexieu6fyjcbbfa"
    },
    "mimeType": "image/jpeg",
    "size": 32526
  },
  "path": "/health/new-pancreatic-cancer-pill-could-reshape-treatment-early-trial-results-stun-researchers",
  "publishedAt": "2026-05-18T11:00:13.000Z",
  "site": "https://www.foxnews.com",
  "tags": [
    "e0fb0cc3-daf8-5490-8cea-41c26a0bc350",
    "fnc",
    "Fox News",
    "fox-news/health",
    "fox-news/health/cancer",
    "fox-news/health/medical-research",
    "fox-news/health/cancer/pancreatic-cancer",
    "fox-news/health/medical-research/cancer-research",
    "fox-news/lifestyle",
    "fox-news/health/healthy-living/medications",
    "article"
  ],
  "textContent": "A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 patients with RAS mutations.",
  "title": "New pancreatic cancer pill could reshape treatment as early trial results stun researchers"
}